non glp 1 weight loss drugs π¨ GLP-1 DRUGS: A BREAKTHROUGH OR A NEW RISK? π€π, π₯ βThe Hidden Side of GLP-1s: Could Weight Loss Trigger Eating Disorders?β π₯, GLP-1 medications such as semaglutide and tirzepatide Prescription Weight Loss Medicine: Exploring
Description
W., Kollman, C., Barnes-Lomen, V., Sulik, M., Haller, M
For the successful clinical implementation of these newly developed multiple hormone receptor agonists, it is essential to elucidate their fundamental mechanisms of action, and at the same time to confirm their efficacy and safety in real-world applications
355:2297-2307 [PubMed: 17135584] 109
Overall, the latest human data on GLP-1 drugs and thyroid cancer risk have not demonstrated a clear causal link between GLP-1 therapy and increased medullary thyroid carcinoma rates
These models typically assess factors like production capacity, demand forecasts, and the impact of rationing on consumer behavior
